Elevance Health, Inc.
ELV
$376.63
$13.893.83%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 222.49% | -53.99% | -31.78% | -20.16% | 422.25% |
| Total Depreciation and Amortization | 189.17% | -202.58% | 1.84% | 1.88% | 211.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.28% | -211.65% | 107.38% | -39.43% | 367.39% |
| Change in Net Operating Assets | 607.63% | 30.13% | -244.04% | 87.79% | -9,816.67% |
| Cash from Operations | 5,057.14% | -92.60% | -44.74% | 101.97% | 44.05% |
| Capital Expenditure | 19.80% | 18.61% | -34.83% | -36.22% | 39.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -84.85% | 3,200.00% | -98.00% | 1,150.00% | 100.11% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -295.03% | 183.70% | -84.04% | -259.32% | -87.73% |
| Cash from Investing | -453.88% | 137.91% | -78.17% | -766.99% | 106.29% |
| Total Debt Issued | -33.40% | -56.02% | 1,256.32% | -68.78% | -83.40% |
| Total Debt Repaid | -278.60% | 73.82% | -1,981.82% | 108.06% | 5.93% |
| Issuance of Common Stock | -36.21% | -- | -- | -- | 43.75% |
| Repurchase of Common Stock | -145.34% | 45.56% | -191.92% | 70.39% | 44.71% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.27% | 1.05% | 1.04% | 0.26% | -3.49% |
| Other Financing Activities | -125.00% | -42.86% | 600.00% | 121.43% | -100.00% |
| Cash from Financing | -1,165.68% | -2.88% | 178.90% | 83.87% | -235.58% |
| Foreign Exchange rate Adjustments | -50.00% | -500.00% | -200.00% | 0.00% | 112.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.66% | 408.50% | -85.57% | 234.52% | -286.73% |